979TiP POPPY: A phase II trial to assess the efficacy and safety profile of pembrolizumab in patients with performance status 2 with recurrent or metastatic squamous cell carcinoma of the head and neck. - Forsyth, S.; Yip, K.; Foran, B.; Gougis, P.; Wheeler, G.; White, L.; Chandrakumar, A.; Blair, K.; Pathak, Y.; Spanswick, V.; Lowe, H.; Hartley, J.; et al. (Annals of Oncology, 2020)